Clinical Trial Update: Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety and efficacy of ShigActive, a bacteriophage product, in a human experimental model of Shigellosis (Phase 1/Phase 2); the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• ShigActive

Snippet

Sponsor: Intralytix, Inc. | Conditions: Shigellosis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING